Feb 2022: I Kina ble en pasient hvis liv var i ferd med å ta slutt fullstendig helbredet for leukemi takket være C-T-cellebehandling, som stimulerte immunsystemet. Alle kreftceller forsvant raskt i den første studien av sitt slag. Immun-mediert terapi, som ble utviklet i USA av ACGT-forskere som Dr. Carl June fra University of Pennsylvania og Dr. Michel Sadelain fra Memorial-Sloan Kettering Cancer Center, blant andre, viser seg raskt mer og mer vellykket i menneskelige forsøk med tusenvis av pasienter.
After being treated with CAR T-cell therapy, a middle-aged woman was reportedly cured of leukaemia. “The cancer cells in her body have vanished. Professor Qian Cheng, director of the Bio-Treatment Center at the hospital in Chongqing, said, “She is the first patient who has been entirely cured of the condition via gene therapy.”
Leukemi har blitt diagnostisert hos omtrent fire millioner mennesker i Kina. CAR T behandling is a gene therapy that uses modified T cells to fight cancer cells in leukaemia patients. Most patients are treated with chemotherapy or bone marrow transplants. “CAR T-terapi er et langt bedre alternativ," sa professor Qian, "siden det kan redusere utgiftene med minst 30 % sammenlignet med benmargstransplantasjoner og er mer sannsynlig å føre til en kur."
According to Professor Qian, six other patients getting gene therapy at the same institution have improved their health. In China, CAR T gene therapy is still in the clinical trial stage, with only ten hospitals across the country having received it. The success has encouraged Qian’s team, which will continue to research doses in order to develop the novel medication.
